Advertisement
Home 2016

Archives

Fear of cancer recurrence seems to be a primary reason why breast cancer patients choose to have their cancer-free breast removed at the same time as their affected breast

ACS: Contralateral Mastectomy Rates Up in Breast CA Patients

0
Reasons include thinking it is the best treatment for breast cancer and fear of recurrence
Vegetarians appear to have no significantly lower risk of cardiovascular disease over 10 years compared to those who eat meat

ACG: Vegetarian Diets May Not Be Significantly Heart Healthier

0
Study finds no significant difference in 10-year cardiovascular risk
Patients undergoing open and laparoscopic mesh hernia repair have lower risk of reoperation for recurrence than those undergoing open repair without use of mesh

ACS: Re-Op Risk Down for Open, Laparoscopic Mesh Hernia Repair

0
But progressively increasing number of mesh-related complications during follow-up
One in five emergency physicians polled said they've had psychiatric patients who needed hospitalization who had to wait two to five days before being assigned an inpatient bed. The findings from the survey were presented at the annual meeting of the American College of Emergency Physicians

ER Visits, Wait Times Up for U.S. Psychiatric Patients

0
One in five emergency doctors report waiting at least two days for a bed for a psychiatric patient
Obstructive sleep apnea may increase risk of developing postoperative atrial fibrillation and venous thromboembolism

CHEST: Odds of Certain Post-Op Issues Up With Sleep Apnea

0
Tied to higher risk of postoperative atrial fibrillation, venous thromboembolism
Pembrolizumab is associated with longer progression-free and overall survival for patients with non-small-cell lung cancer with programmed death ligand 1 expression on at least 50 percent of tumor cells

Pembrolizumab Ups Survival in NSCLC With PD-L1 Expression

0
Findings in patients with advanced NSCLC with PD-L1 expression on at least 50 percent of tumor cells
The duration of disease-free survival is increased with sunitinib treatment for patients with locoregional

Renal-Cell Cancer Disease-Free Survival Up With Sunitinib

0
Findings in patients with locoregional, high-risk clear-cell renal-cell carcinoma
Nivolumab is associated with longer overall survival than standard single-agent therapy in patients with platinum-refractory

Nivolumab Ups Overall Survival in Head, Neck Cancer

0
Longer overall survival compared with single-agent therapy for platinum-refractory squamous-cell cancer
Ribociclib plus letrozole is associated with significantly longer progression-free survival for patients receiving initial systemic treatment for hormone receptor-positive

Ribociclib + Letrozole Beneficial in Advanced Breast Cancer

0
Longer duration of progression-free survival in patients with HR+, HER2− breast cancer
For high-risk critically ill patients who have undergone extubation

High-Flow Oxygen Not Inferior for Averting Reintubation

0
Not inferior to noninvasive mechanical ventilation for high-risk patients who have undergone extubation